We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
(+125%)
Cap. Flow
+$28.6B
Cap. Flow
% of AUM
52.81%
Top 10 Holdings %
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.08B |
| 2 |
Amazon
AMZN
|
+$1B |
| 3 |
Meta Platforms (Facebook)
META
|
+$844M |
| 4 |
Apple
AAPL
|
+$842M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$725M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$192M |
| 2 |
West Pharmaceutical
WST
|
+$107M |
| 3 |
Advanced Micro Devices
AMD
|
+$97.2M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$79.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$79.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.77% |
| 2 | Healthcare | 17.47% |
| 3 | Financials | 15.58% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Communication Services | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FST
601
DELISTED
FAST Acquisition Corp.
FST
| $15.2M | 0.03% |
+1,500,000
| New | +$17.4M |
|
|
HIGA
602
DELISTED
H.I.G. Acquisition Corp.
HIGA
| $15.2M | 0.03% |
1,554,650
+60,831
| +4% | +$597K |
|
603
Biote Corp
BTMD
$68.2M
| $15.2M | 0.03% |
1,544,160
+602,246
| +64% | +$5.88M |
|
|
X
604
CALL
DELISTED
US Steel
X
| $15.2M | 0.03% |
636,900
-139,200
| -18% | -$3.28M |
|
605
Petrobras
PBR
$125B
| $15.1M | 0.03% |
1,375,858
+1,259,670
| +1,084% | +$13.3M |
|
|
FOUN
606
DELISTED
Founder SPAC Class A Ordinary Shares
FOUN
| $15.1M | 0.03% |
+1,515,829
| New | +$15M |
|
|
WIRE
607
DELISTED
Encore Wire Corp
WIRE
| $15.1M | 0.03% |
105,302
+84,870
| +415% | +$11M |
|
608
PUT
State Street Utilities Select Sector SPDR ETF
XLU
$22.8B
| $15M | 0.03% |
418,800
+400
| +0.1% | +$13.5K |
|
609
Tapestry
TPR
$30.8B
| $15M | 0.03% |
368,448
-16,976
| -4% | -$698K |
|
610
CALL
Gilead Sciences
GILD
$162B
| $14.9M | 0.03% |
205,000
-93,900
| -31% | -$6.47M |
|
611
Zions Bancorporation
ZION
$10.2B
| $14.9M | 0.03% |
235,425
+228,613
| +3,356% | +$14.6M |
|
|
LDTC
612
DELISTED
LeddarTech
LDTC
| $14.9M | 0.03% |
3,051,080
+613,950
| +25% | +$2.99M |
|
|
ROSS
613
DELISTED
Ross Acquisition Corp II
ROSS
| $14.8M | 0.03% |
1,520,433
+61,250
| +4% | +$600K |
|
|
SDAC
614
DELISTED
Sustainable Development Acquisition I Corp. Class A Common Stock
SDAC
| $14.8M | 0.03% |
1,522,189
+605,518
| +66% | +$5.91M |
|
|
NVTA
615
DELISTED
Invitae Corporation
NVTA
| $14.8M | 0.03% |
+968,587
| New | +$21M |
|
|
ZGNX
616
DELISTED
Zogenix, Inc.
ZGNX
| $14.8M | 0.03% |
909,034
-1,142,872
| -56% | -$16.7M |
|
|
QNGY
617
DELISTED
Quanergy Systems, Inc.
QNGY
| $14.8M | 0.03% |
73,717
+49,708
| +207% | +$9.95M |
|
618
Vir Biotechnology
VIR
$1.46B
| $14.7M | 0.03% |
352,171
+293,552
| +501% | +$11.5M |
|
619
Huazhu Hotels Group
HTHT
$13.1B
| $14.7M | 0.03% |
394,070
+266,370
| +209% | +$11.6M |
|
620
Canadian National Railway
CNI
$76.9B
| $14.7M | 0.03% |
119,645
+48,540
| +68% | +$6.15M |
|
|
ZINGU
621
DELISTED
FTAC Zeus Acquisition Corp. Unit
ZINGU
| $14.7M | 0.03% |
+1,470,000
| New | +$14.8M |
|
|
KVSC
622
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
| $14.7M | 0.03% |
1,504,259
| – | – |
|
|
GXII
623
DELISTED
GX Acquisition Corp. II Class A Common Stock
GXII
| $14.6M | 0.03% |
1,499,883
| – | – |
|
|
ESM
624
DELISTED
ESM Acquisition Corporation
ESM
| $14.6M | 0.03% |
1,497,129
+270,322
| +22% | +$2.63M |
|
625
California Resources
CRC
$4.67B
| $14.5M | 0.03% |
338,890
+185,036
| +120% | +$7.92M |
|
Similar funds
Marshall Wace's Q4 2021 Portfolio in Review
As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.
- Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
- Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
- Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
- Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
- Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
- Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
- Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.
Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.